Related Experiment Video
Updated: Jun 5, 2025

10:00
Assessment of Selective mRNA Translation in Mammalian Cells by Polysome Profiling
Published on: October 28, 2014
28.1K
Codon optimality modulates cellular stress and innate immune responses triggered by exogenous RNAs.
Chotiwat Seephetdee1,2,3,4, Daniel L Kiss1,2,3,5,6,4
1Center for RNA Therapeutics, 6670 Bertner Ave, Houston, TX 77030 USA.
Biorxiv : the Preprint Server for Biology
|December 9, 2024
Summary
Optimizing messenger RNA (mRNA) sequences enhances protein production and reduces cellular stress and immune responses. Combining sequence, chemical, and structural modifications improves therapeutic potential.
Area of Science:
- Biochemistry
- Molecular Biology
- Immunology
Background:
- The success of COVID-19 mRNA vaccines highlights the potential of mRNA therapeutics.
- Limited data exists on how synonymous codon usage impacts cellular stress and innate immunity.
- Understanding these factors is crucial for designing effective mRNA-based therapies.
Purpose of the Study:
- To investigate the impact of synonymous codon optimization on mRNA translatability, cellular stress, and innate immune responses.
- To explore how RNA modifications (nucleoside modification, circularization) affect these outcomes.
- To provide insights into engineering mRNA sequences for improved therapeutic applications.
Main Methods:
- Developed a proprietary codon optimality matrix to re-engineer luciferase reporter mRNA sequences.
- Assessed luciferase activity in various cell lines using dual-luciferase assays.
- Analyzed innate immune pathway activation and integrated stress response markers (e.g., eIF2α phosphorylation).
- Investigated the effects of nucleoside modification and RNA circularization.
Main Results:
- Optimally engineered mRNAs showed significantly higher luciferase activity compared to non-optimal sequences.
- Non-optimal mRNAs triggered innate immune pathways and the integrated stress response.
- Nucleoside modification and circularization partially or fully abrogated these adverse responses.
- Circular RNA formation enhanced RNA stability and protein expression durability.
Conclusions:
- RNA sequence, composition, and structure are critical determinants of translatability and immunogenicity.
- Suboptimal codon usage in mRNA can induce cellular stress and immune activation.
- A combined approach involving sequence optimization, chemical modification, and topological engineering is necessary for favorable therapeutic outcomes in mRNA medicine.
Related Concept Videos
Types of RNA
63.2K
Overview
Three main types of RNA are involved in protein synthesis: messenger RNA (mRNA), transfer RNA (tRNA), and ribosomal RNA (rRNA). These RNAs perform diverse functions and can be broadly classified as protein-coding or non-coding RNA. Non-coding RNAs play important roles in the regulation of gene expression in response to developmental and environmental changes. Non-coding RNAs in prokaryotes can be manipulated to develop more effective antibacterial drugs for human or animal use.
RNA...
Three main types of RNA are involved in protein synthesis: messenger RNA (mRNA), transfer RNA (tRNA), and ribosomal RNA (rRNA). These RNAs perform diverse functions and can be broadly classified as protein-coding or non-coding RNA. Non-coding RNAs play important roles in the regulation of gene expression in response to developmental and environmental changes. Non-coding RNAs in prokaryotes can be manipulated to develop more effective antibacterial drugs for human or animal use.
RNA...
63.2K
lncRNA - Long Non-coding RNAs
8.5K
In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
8.5K
Regulation of Expression at Multiple Steps
869
The gene expression in cells is regulated at different stages: (i) transcription, (ii) RNA processing, (iii) RNA localization, and (iv) translation. Transcriptional regulation is mediated by regulatory proteins such as transcription factors, activators, or repressors—these control gene expression by initiating or inhibiting the transcription of genes. Once a precursor or pre-mRNA is produced, it undergoes post-transcriptional modification, including 5' capping, splicing, and the...
869
RNA Stability
33.3K
Intact DNA strands can be found in fossils, while scientists sometimes struggle to keep RNA intact under laboratory conditions. The structural variations between RNA and DNA underlie the differences in their stability and longevity. Because DNA is double-stranded, it is inherently more stable. The single-stranded structure of RNA is less stable but also more flexible and can form weak internal bonds. Additionally, most RNAs in the cell are relatively short, while DNA can be up to 250 million...
33.3K
Nuclear Export of mRNA
7.5K
Before mRNAs are exported to the cytoplasm, it is crucial to check each mRNA for structural and functional integrity. Eukaryotic cells use several different mechanisms, collectively known as mRNA surveillance, to look for irregularities in mRNAs. Irregular or aberrant mRNA are rapidly degraded by various enzymes. If a defective mRNA escapes the surveillance, it would be translated into a protein which would either be non-functional or not function properly. One of the primary irregularities in...
7.5K
RNA Interference
25.9K
RNA interference (RNAi) is a process in which a small non-coding RNA molecule blocks the post-transcriptional expression of a gene by binding to its messenger RNA (mRNA) and preventing the protein from being translated.
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
25.9K

